Previous close | 0.2500 |
Open | 0.2500 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 2.50 |
Expiry date | 2024-07-19 |
Day's range | 0.2500 - 0.2600 |
Contract range | N/A |
Volume | |
Open interest | 463 |
ORLANDO, Fla., June 03, 2024--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees stock options to purchase an aggregate of 2,150 shares of the Company’s common stock. The options were granted as of June 3, 2024, as inducements material to each employee entering into employment with the Company. The options were granted in accordance with Nasdaq Listing
ORLANDO, Fla., May 23, 2024--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer, will participate in a Fireside Chat at the 2024 Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024, at 1:40 p.m. CT in Austin, TX.
LENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Call Transcript May 11, 2024 LENSAR, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and thank you for your participation. At this time, all participants are in a listen-only mode. Later […]